image
Technology - Information Technology Services - NYSE - GB
$ 3.37
-0.882 %
$ 2.32 B
Market Cap
-3.51
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CLVT stock under the worst case scenario is HIDDEN Compared to the current market price of 3.37 USD, Clarivate Plc is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CLVT stock under the base case scenario is HIDDEN Compared to the current market price of 3.37 USD, Clarivate Plc is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one CLVT stock under the best case scenario is HIDDEN Compared to the current market price of 3.37 USD, Clarivate Plc is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CLVT

image
$7.0$7.0$6.5$6.5$6.0$6.0$5.5$5.5$5.0$5.0$4.5$4.5$4.0$4.0$3.5$3.5$3.0$3.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
2.56 B REVENUE
-2.74%
-276 M OPERATING INCOME
62.49%
-637 M NET INCOME
30.13%
647 M OPERATING CASH FLOW
-13.11%
-237 M INVESTING CASH FLOW
0.29%
-470 M FINANCING CASH FLOW
5.32%
663 M REVENUE
6.56%
-62.3 M OPERATING INCOME
-287.10%
-192 M NET INCOME
-192.38%
141 M OPERATING CASH FLOW
-30.36%
21.4 M INVESTING CASH FLOW
123.39%
-240 M FINANCING CASH FLOW
-118.41%
Balance Sheet Clarivate Plc
image
Current Assets 1.24 B
Cash & Short-Term Investments 295 M
Receivables 798 M
Other Current Assets 151 M
Non-Current Assets 10.2 B
Long-Term Investments 0
PP&E 107 M
Other Non-Current Assets 10.1 B
6.95 %88.24 %Total Assets$11.5b
Current Liabilities 1.43 B
Accounts Payable 124 M
Short-Term Debt 20.6 M
Other Current Liabilities 1.29 B
Non-Current Liabilities 4.92 B
Long-Term Debt 4.57 B
Other Non-Current Liabilities 346 M
20.29 %71.98 %5.44 %Total Liabilities$6.4b
EFFICIENCY
Earnings Waterfall Clarivate Plc
image
Revenue 2.56 B
Cost Of Revenue 869 M
Gross Profit 1.69 B
Operating Expenses 1.96 B
Operating Income -276 M
Other Expenses 361 M
Net Income -637 M
3b3b3b3b2b2b2b2b1b1b500m500m00(500m)(500m)(1b)(1b)3b(869m)2b(2b)(276m)(361m)(637m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
66.00% GROSS MARGIN
66.00%
-10.78% OPERATING MARGIN
-10.78%
-26.13% NET MARGIN
-26.13%
-13.00% ROE
-13.00%
-5.81% ROA
-5.81%
-3.14% ROIC
-3.14%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Clarivate Plc
image
600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -637 M
Depreciation & Amortization 727 M
Capital Expenditures -289 M
Stock-Based Compensation 59.9 M
Change in Working Capital -24.9 M
Others 398 M
Free Cash Flow 358 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Clarivate Plc
image
Wall Street analysts predict an average 1-year price target for CLVT of $14.3 , with forecasts ranging from a low of $11 to a high of $20 .
CLVT Lowest Price Target Wall Street Target
11 USD 226.41%
CLVT Average Price Target Wall Street Target
14.3 USD 325.32%
CLVT Highest Price Target Wall Street Target
20 USD 493.47%
Price
Max Price Target
Min Price Target
Average Price Target
20201818161614141212101088664422May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 12
6. Ownership
Insider Ownership Clarivate Plc
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
420 K USD 1
6-9 MONTHS
959 K USD 2
9-12 MONTHS
0 USD 0
Bought
1.54 M USD 4
0-3 MONTHS
17.9 M USD 1
3-6 MONTHS
1.64 M USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Clarivate to Report First Quarter 2025 Results on April 29, 2025 LONDON , April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. prnewswire.com - 1 week ago
Clarivate Partners with Iprova to Streamline the Invention Creation and Submission Process The partnership will see Iprova's suite of solutions integrated with IP management software IPfolio LONDON , March 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a strategic partnership with Iprova, the world's first data-driven invention company and developer of state-of-the-art Artificial Intelligence-based technologies which augment and enhance the human ability to invent. This partnership will combine Iprova's product suite for collaboratively capturing, creating and refining inventive concepts with IPfolio, the industry-leading IP management software, enabling a smooth transition of inventions into the patent workflow. prnewswire.com - 3 weeks ago
TE Connectivity ranks among Clarivate Top 100 Global Innovators 2025 List highlights organizations at the forefront of technology research and innovation GALWAY, Ireland , March 12, 2025 /PRNewswire/ -- TE Connectivity, a world leader in connectors and sensors, has been named among the Clarivate Top 100 Global Innovators, an annual list of organizations that prioritize innovation as a business strategy. Innovation is a core value at TE, which has been named a Top 100 Global Innovator 12 times since Clarivate created the recognition in 2012. prnewswire.com - 1 month ago
Philips highest ranked medical technology company among Clarivate Top 100 Global Innovators March 12, 2025 Amsterdam, the Netherlands –  Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global Innovators 2025, reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, Philips has been included in this major assessment of global innovators for 12 consecutive years. Roy Jakobs, CEO of Royal Philips said: "At Philips, we've been innovating for over 130 years to improve people's lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people." In 2024, Philips invested approximately EUR 1.7 billion – or an industry leading >9% of sales – in research and development to help drive better care for more people. Philips is increasingly focusing its innovation efforts on the potential of data and AI, both in hospital settings and at home. As a leader in AI-related patent applications in healthcare, Philips dedicates around half of its R&D workforce to these fields.  Examples of Philips' AI-powered innovations that increase caregiver productivity and deliver better care for more people include: globenewswire.com - 1 month ago
Clarivate Reveals Top 100 Global Innovators 2025 The Top 100 organizations generate $4.6 trillion USD in annual revenues, representing 4.4% of the global economy LONDON , March 12, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today revealed its 2025 ranked list of Top 100 Global Innovators – the organizations at the forefront of technology research and innovation worldwide. The Top 100 organizations prioritize innovation as a central part of their business strategy. prnewswire.com - 1 month ago
Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON , Feb. 27, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) a leading global provider of transformative intelligence, has released a new white paper, How is Latin America Growing? , shedding light on the pharmaceutical industry's evolution in the region. prnewswire.com - 1 month ago
Clarivate Plc (CLVT) Q4 2024 Earnings Call Transcript Clarivate Plc (NYSE:CLVT ) Q4 2024 Earnings Conference Call February 19, 2025 9:00 AM ET Company Participants Mark Donohue - VP of IR Matti Shem Tov - CEO Jonathan Collins - CFO Conference Call Participants Manav Patnaik - Barclays Andrew Nicholas - William Blair George Tong - Goldman Sachs Owen Lau - Oppenheimer Shlomo Rosenbaum - Stifel Surinder Thind - Jefferies Peter Christiansen - Citi Ashish Sabadra - RBC Capital Markets Operator Thank you for standing by. My name is Kate, and I will be your conference operator today. seekingalpha.com - 1 month ago
Compared to Estimates, Clarivate (CLVT) Q4 Earnings: A Look at Key Metrics Although the revenue and EPS for Clarivate (CLVT) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com - 1 month ago
Clarivate PLC (CLVT) Q4 Earnings and Revenues Top Estimates Clarivate PLC (CLVT) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.23 per share a year ago. zacks.com - 1 month ago
Clarivate Reports Fourth Quarter and Full Year 2024 Results — Accelerates transition from transactional to subscription and re-occurring revenue — — Launches new product innovation for Academia & Government and Life Sciences & Healthcare — — Repurchased $200 million ordinary shares and pre-paid $198 million of debt in 2024 as part of balanced capital allocation strategy — — Initiates review of strategic alternatives including potential divestitures — — Provides 2025 Outlook — LONDON , Feb. 19, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the fourth quarter and full year ended December 31, 2024. Total revenue for the fourth quarter of 2024 was $663.0 million, compared to total revenue of $683.7 million in the fourth quarter of 2023. prnewswire.com - 1 month ago
Clarivate Unveils Transformative Subscription-Based Access Strategy for Academia New approach enables broad, simple and affordable access to trusted scholarly content for learning and research LONDON , Feb. 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new subscription-based content access strategy. The new approach breaks down barriers through broad and affordable access to highly curated, trusted academic resources, including Ebooks and primary digital collections, enabling every library to support research, teaching and learning goals. prnewswire.com - 1 month ago
Exploring Analyst Estimates for Clarivate (CLVT) Q4 Earnings, Beyond Revenue and EPS Beyond analysts' top -and-bottom-line estimates for Clarivate (CLVT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024. zacks.com - 1 month ago
8. Profile Summary

Clarivate Plc CLVT

image
COUNTRY GB
INDUSTRY Information Technology Services
MARKET CAP $ 2.32 B
Dividend Yield 0.00%
Description Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Contact 70 St. Mary Axe, London, EC3A 8BE https://www.clarivate.com
IPO Date Oct. 29, 2018
Employees 12000
Officers Mr. Mark J. Donohue CPA Head of Investor Relations Mr. Henry Levy President of Life Sciences & Healthcare Mr. Gordon Samson President of Intellectual Property Ms. Darien Krimmert Senior Vice President & Head of People Ms. Tabita Andersson Senior Vice President of Communications & Brand Mr. John Doulamis Senior Vice President & General Counsel Mr. Bar Veinstein President of Academia & Government Mr. Jonathan M. Collins Executive Vice President & Chief Financial Officer Mr. Michael Easton Senior Vice President of Finance & Chief Accounting Officer Mr. William E. Graff Executive Vice President & Chief Information Officer